This review summarizes the key points for hospitalist physicians included in the 2019 Infectious Disease Society of America guidelines for community acquired pneumonia. a) routine blood cultures, sputum cultures, and urinary antigen tests are not routinely recommended unless severe CAP; b) PSI and CURB-65 scores are not very helpful in risk stratification; c) in patients at low risk for MRSA or pseudomonas, recommended antibiotics in nonsevere pneumonia are either (a beta lactam + macrolide) OR a fluoroquinolone; d) in severe pneumonia a beta lactam + (macrolide OR fluoroquinolone) is recommended assuming low risk for MRSA or pseudomonas; e) anaerobic coverage is not necessary in suspected aspiration pneumonia; F) corticosteroids are not routinely indicated in nonsevere pneumonia; g) empiric coverage for MRSA and/or pseudomonas should be started in selected high risk patients only; h) continue antibiotics for at least 5 days.
J Hosp Med . 2020 Aug 19. (retrieved Sep, 2020).
There are currently 1090 pearls in the database. While every attempt has been made to ensure accuracy, mistakes can and do occur. Use databank at your own risk.
All pearls © 2024 by the Internet Medical Association. Click Here to view more medical pearls.
|